Business
Novavax COVID-19 vaccine production set back due to supply shortages – ABC News
Novavax pushes back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month due to supply shortages, dealing another blow…
Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages, dealing another blow to the federal government’s rollout plans.
Key points:
- Novavax is one of three companies the federal government struck a deal with to distribute COVID-19 vaccines in Australia
- It will need to be imported to Australia because of a lack of capable vaccine manufacturers
- The company has faced difficulties sourcing…
-
Business22 hours agoWhy Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher
-
Business23 hours agoMacquarie increases price target for Qantas shares
-
Noosa News24 hours agoHoyts Is Set to Launch Up to Five New IMAX Screens in Australia — Including at Melbourne Central Before the End of 2025
-
Noosa News22 hours agoCommonwealth Bank executive Christopher James McCann found dead in Springbrook National Park